In one paragraphArticle in Pharmacogenomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors at 9 institutions in 2 countries.
Delaney V RutherfordDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0009-0002-4088-9281 Sarah MedleyDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.ORCID 0009-0006-1310-3051 Nicholas C HendersonDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.ORCID 0000-0003-3184-0945 Christina L GerschDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0001-7381-6703 Nagendra R TirumaliKaiser Permanente, Beaverton, OR 97005, USA.
Rita S MehtaUniversity of California Irvine Medical Center, Chao Family Comprehensive Cancer Center, Orange, CA 92868, USA.
Daniel F HayesDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0003-3620-7575 Kelley M KidwellDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.ORCID 0000-0002-1717-4483 N Lynn HenryDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-4771-5930 James M RaeDepartment of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-3412-8219 Daniel L HertzDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.ORCID 0000-0003-0501-1035 University of Michigan · USAmerican Society of Clinical Oncology · USCancer Center of Kansas · USKaiser Permanente · USLoyola University Chicago · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Irvine Medical Center · USWestern University · CAYale University · US
Funding
SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1MSWOG Statistics & Data Management Center complex - extension supplement for GY06U10CA180819 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Michael L. LeBlanc · 2014 to 2026
$115.2MYale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MUniv.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9MKaiser Permanente NCI National Community Oncology Research Program, NCORPUG1CA189821 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI Jennifer Marie Suga · 2014 to 2026
$44.4MNCIC Clinical Trials Group - Canadian Collaborating Clinical Trials NetworkU10CA180863 · NCI · QUEEN'S UNIVERSITY AT KINGSTON · PI Janet Ellen Dancey · 2014 to 2026
$40.4MUT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1UG1CA233329 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KELLY K HUNT, CHELSEA Camille PINNIX · 2019 to 2026
$11.1MNational Community Oncology Research ProjectUG1CA189808 · NCI · VIA CHRISTI REGIONAL MEDICAL CENTER · PI DAKHIL, SHAKER R · 2014 to 2018
$8.6MUM LAPs -UG1 GrantUG1CA233160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANNE F SCHOTT · 2019 to 2026
$5.4MNCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA062203NCI NIH HHS U10 CA180819NCI NIH HHS U10 CA180863NCI NIH HHS U10 CA180888NCI NIH HHS UG1 CA189808NCI NIH HHS UG1 CA189821NCI NIH HHS UG1 CA233160NCI NIH HHS UG1 CA233329
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Breast NeoplasmsCytochrome P-450 CYP3AAnastrozoleAntineoplastic Agents, HormonalCytochrome P-450 CYP2C9EstradiolFemaleFulvestrantGenotypeHumansNitrilesTriazolesAnastrozoleAntineoplastic Agents, HormonalCYP2C9 protein, humanCYP3A4 protein, humanCytochrome P-450 CYP2C9Cytochrome P-450 CYP3AEstradiolFulvestrantNitrilesTriazolesanastrozoledrug–drug interactionfulvestrantmetabolismpharmacogeneticspharmacokinetics
Identifiers
PMID37615099
PMCPMC10565537
OpenAlexW4386116271
What OpenQuestion holds
Textmetadata
Read underepoch 390